VAXIMM reports positive follow-on data from oral cancer vaccine trial
Phase I study evaluating safety and tolerability of VXM01 in pancreatic cancer...
List view / Grid view
News
US sales of Sanofi/Regeneron’s Dupilumab for atopic dermatitis could exceed $1.3 Billion by 2022, says GlobalData Analyst
4 December 2014 | By GlobalData
The first biologic to treat atopic dermatitis, Sanofi and Regeneron’s dupilumab, could launch in the US by Q2 2017, and the potentially game-changing drug could achieve annual sales of over $1.3 billion in this market by 2022, according to an analyst with research and consulting firm GlobalData.
Santen announces appointment of Paolo Casati as General Manager of Santen Subsidiary in Italy
4 December 2014 | By Santen
Following the launch of Santen in Italy in October 2014, Santen Italy s.r.l (Milano, Italy) (Santen) announces that Paolo Casati has been named General Manager of Santen Italy, effective November 21st, 2014...
Bioquell publishes norovirus information tools
4 December 2014 | By Bioquell
Norovirus season is upon us and Bioquell has issued tools to help combat the spread...
Bristol-Myers Squibb Foundation awards nine grants totaling more than $3.5 million to support care for high-risk patients with hepatitis B and C in China and India
4 December 2014 | By Bristol-Myers Squibb Foundation
The Bristol-Myers Squibb Foundation announced nine new grants totaling more than $3.5 million to strengthen efforts in China and India in the fight against hepatitis B virus (HBV) and hepatitis C virus (HCV) infection by focusing on the most vulnerable, high-risk patient populations...
Sagentia selected as lead development partner for Chrono Therapeutics’ wearable ‘smart’ smoking cessation device
3 December 2014 | By Sagentia
Sagentia, a global science, product and technology development company, announced today that it is working with Chrono Therapeutics on the development of SmartStop™, the world’s first programmable and wearable nicotine delivery device to help people quit smoking...
Age-related macular degeneration treatment market value to exceed $10 billion by 2023
3 December 2014 | By GlobalData
The Age-related Macular Degeneration treatment market across seven major countries (the US, UK, Germany, France, Spain, Italy and Japan) will almost double in value from $5.1 billion in 2013 to $10.1 billion by 2023, according to research and consulting firm GlobalData.
Prothena initiates NEOD001 global Phase 3 registrational trial based on positive results in ongoing phase 1/2 study
3 December 2014 | By Prothena
Prothena initiates NEOD001 global Phase 3 registrational trial based on positive results in ongoing phase 1/2 study of NEOD001 in Patients With AL Amyloidosis...
NICE reverses decision on access to new blood cancer drug
2 December 2014 | By Roche
Victory for patients as NICE accepts Gazyvaro™ (obinutuzumab) for treatment of most common adult leukaemia1...
Ebola: Ask your questions LIVE to the Chief Medical Officer of the Ministry of Health and Sanitation of Sierra Leone
2 December 2014 | By The Republic of Sierra Leone
The Chief Medical Officer of the Ministry of Health and Sanitation, Dr Brima Kargbo, will host an online press conference on Wednesday, December 3rd, 2014 at 15 GMT...
Survivors take spotlight in new campaign to end West Africa’s Ebola outbreak
2 December 2014 | By Distributed by APO (African Press Organization) on behalf of #TackleEbola
The multimedia campaign is the first to directly engage Ebola survivors in delivering key protective messages...
Inventiva receives another positive opinion on orphan drug designation in the European Union for IVA337 – for Idiopathic Pulmonary Fibrosis
2 December 2014 | By Inventiva
This follows an earlier positive opinion for IVA337 in October regarding the treatment of Systemic Sclerosis (SSc)...
Exco InTouch address mHealth solutions in management of chronic conditions at 2014 mHealth Summit
2 December 2014 | By Exco InTouch
Exco InTouch, the leading provider of digital patient engagement and data capture solutions for clinical research and healthcare providers, will speak in two mHealth Solutions sessions focused on disease management at the annual mHealth Summit on Monday, 8th and Tuesday 9th December 2014...
Roche acquires Ariosa Diagnostics and enters the non-invasive prenatal test (NIPT) and cell-free DNA testing services markets
2 December 2014 | By Roche
Roche announced the acquisition of Ariosa Diagnostics, Inc. (Ariosa), a privately-held company based in San Jose, California, USA...
Bristol-Myers Squibb Foundation marks World AIDS Day by awarding $1.47 million in new grants to strengthen HIV-related services in five sub-Saharan countries
2 December 2014 | By The Bristol-Myers Squibb Foundation
The Bristol-Myers Squibb Foundation marked World AIDS Day by announcing 12 new grants totaling $1.47 million that focus on strengthening community-based services in sub-Saharan Africa for adolescents and the elderly who are living with HIV and for HIV patients with comorbid female cancers or tuberculosis...
